BioSpace News Archive

Press Releases

Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem

October 28, 2024
·
5 min read
Press Releases

Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates

October 28, 2024
·
4 min read
Press Releases

Monte Rosa Therapeutics Announces Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders

October 28, 2024
·
7 min read
Press Releases

Purespring Therapeutics presents new preclinical data on novel gene therapy for IgA Nephropathy at ASN Kidney Week 2024

October 28, 2024
·
4 min read
Press Releases

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024

October 28, 2024
·
7 min read
Press Releases

Parabilis Medicines™ – Formerly FogPharma – Announces New Company Name and Unveils AI- and Physics-Based Discovery Platform

October 28, 2024
·
3 min read
Press Releases

Lilly’s mirikizumab is first and only IL23p19 antagonist to report long-term, multi-year, sustained efficacy and safety data for both ulcerative colitis and Crohn’s disease

October 28, 2024
·
14 min read
Press Releases

Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies

October 28, 2024
·
4 min read
Press Releases

Castle Biosciences to Participate in Upcoming Investor Conferences

October 28, 2024
·
1 min read
Press Releases

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

October 28, 2024
·
17 min read